12 Best NASDAQ Stocks to Buy in 2026

10. Masimo Corporation (NASDAQ:MASI)

Forward EPS Diluted Growth (1-Year Estimate): 48.44%

Average Upside Potential as of December 30: 39.71%

Number of Hedge Fund Holders: 31

Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the firm’s price target on Masimo to $190 from $187, while maintaining an Overweight rating on the shares. The firm observed that the company’s Investor Day underscored a strong belief in its sustained, multi-year expansion. Wells Fargo specifically highlighted an expected annual revenue growth rate of 7% to 10% through 2028 and noted that the introduction of new products is projected to push that growth into double digits after 2028.

On the same day, BTIG raised the firm’s price target on Masimo to $200 from $198 and kept a Buy rating on the shares. Following the company’s Investor Day, BTIG expressed a bullish outlook and positioned Masimo as a potential top-tier performer in the MedTech sector for years to come. The firm highlighted the company’s commitment to funding next-generation sensors and monitors. BTIG believes that this focus on R&D will secure sustainable and high-single-digit growth.

In Q3 2025, Masimo Corporation (NASDAQ:MASI) reported an 8% increase in total revenue to $371 million. The company also saw a 38% year-over-year surge in adjusted EPS, which reached $1.32. This performance was supported by new contracts valued at $124 million, which was a 48% increase from the previous year. The company also reported a substantial backlog, with $507 million in unrecognized contract revenue expected to be realized within the next 12 months.

Masimo also raised its full-year 2025 guidance, now projecting annual revenue between $1.510 and $1.530 billion, with an adjusted EPS of $5.40 to $5.55.

Masimo Corporation (NASDAQ: MASI) develops, manufactures, and markets various patient monitoring technologies, as well as automation and connectivity solutions, worldwide.